Subscribe
shutterstock_1443758708_fotohelin
FotoHelin / Shutterstock.com
23 May 2022GenericsKareema Shaik and Jenny Pienaar

South Africa: homeopathy case clarifies ‘medicine’ definition

In August 2017, South Africa’s Minister of Health, Aaron Motsoaledi, issued updated General Regulations (“the Regulations”) in terms of the Medicines and Related Substances Act 101 of 1965.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.
Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.
Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.

More on this story

Africa
MSF urges South Africa to open access to COVID-19 generics
10 February 2022   Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.
Big Pharma
US, EU, India and South Africa reach COVID waiver ‘compromise’
16 March 2022   The US, EU, India and South Africa have reached an undisclosed agreement related to the stonewalled COVID-19 vaccine IP waiver.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
Comparing life sciences IP in Brazil and the US
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
Astellas defends blockbuster cancer treatment patent
How to navigate patent term adjustment in China